We Think Poltreg (WSE:PTG) Needs To Drive Business Growth Carefully
Dec 24
Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedDec 31, 2024
DataAggregated Company Financials
Companies12
- 7D3.4%
- 3M-13.5%
- 1Y-24.5%
- YTD-25.4%
The Biotech industry is up 1.6% in the last week, with Bioceltix up 5.4%. However, the industry is down 25% over the past year. Earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 31 Dec 2024 | zł1.9b | zł408.7m | -zł84,434,269.00 | 40.1x | -22.1x | 4.6x |
| Thu, 28 Nov 2024 | zł1.9b | zł407.0m | -zł85,360,565.00 | 39.2x | -22.4x | 4.7x |
| Sat, 26 Oct 2024 | zł2.2b | zł438.7m | -zł64,845,969.00 | 62.4x | -33.2x | 4.9x |
| Mon, 23 Sep 2024 | zł2.1b | zł442.8m | -zł53,911,969.00 | 62.8x | -39x | 4.8x |
| Wed, 21 Aug 2024 | zł2.2b | zł445.0m | -zł63,393,784.00 | 65.5x | -34.5x | 4.9x |
| Fri, 19 Jul 2024 | zł2.1b | zł444.2m | -zł64,230,755.00 | 72x | -32.9x | 4.8x |
| Sun, 16 Jun 2024 | zł2.1b | zł439.7m | -zł90,277,755.00 | 71x | -23x | 4.7x |
| Tue, 14 May 2024 | zł2.3b | zł441.3m | -zł90,006,665.00 | 56.9x | -25.5x | 5.2x |
| Thu, 11 Apr 2024 | zł2.3b | zł432.0m | -zł73,964,007.00 | 62.2x | -30.7x | 5.3x |
| Sat, 09 Mar 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 60.6x | -31.1x | 5x |
| Mon, 05 Feb 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 85x | -40.5x | 5.4x |
| Wed, 03 Jan 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 89.9x | -40.9x | 5.5x |
| Fri, 01 Dec 2023 | zł2.6b | zł499.9m | -zł66,755,911.00 | 95x | -38.5x | 5.1x |
| Sun, 29 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 46.3x | -44x | 5.2x |
| Tue, 26 Sep 2023 | zł2.7b | zł518.5m | -zł61,744,678.00 | 49.4x | -44.5x | 5.3x |
| Thu, 24 Aug 2023 | zł2.8b | zł520.3m | -zł43,292,668.00 | 50.1x | -64.8x | 5.4x |
| Sat, 22 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 54.3x | -68.4x | 5.6x |
| Mon, 19 Jun 2023 | zł2.8b | zł517.3m | -zł42,548,721.00 | 62.6x | -66.8x | 5.5x |
| Wed, 17 May 2023 | zł2.9b | zł520.8m | -zł42,603,826.00 | 66.5x | -68.3x | 5.6x |
| Fri, 14 Apr 2023 | zł2.8b | zł492.8m | -zł18,098,449.00 | 62.1x | -156.3x | 5.7x |
| Sun, 12 Mar 2023 | zł2.8b | zł488.6m | -zł16,165,349.00 | 64.2x | -173.9x | 5.8x |
| Tue, 07 Feb 2023 | zł3.0b | zł496.5m | -zł10,783,764.00 | 47.1x | -274.2x | 6x |
| Thu, 05 Jan 2023 | zł2.9b | zł496.5m | -zł10,783,764.00 | 48.7x | -266.2x | 5.8x |
| Sat, 03 Dec 2022 | zł2.7b | zł457.9m | -zł19,209,766.00 | 45x | -141.9x | 6x |
| Mon, 31 Oct 2022 | zł2.7b | zł444.0m | -zł13,473,868.00 | 58.2x | -197.2x | 6x |
| Wed, 28 Sep 2022 | zł2.6b | zł390.2m | -zł18,886,868.00 | 57.4x | -136.3x | 6.6x |
| Fri, 26 Aug 2022 | zł2.9b | zł390.2m | -zł7,043,258.00 | 62.3x | -405.3x | 7.3x |
| Sun, 24 Jul 2022 | zł2.5b | zł472.9m | zł66,686.00 | 27.1x | 37861.6x | 5.3x |
| Tue, 21 Jun 2022 | zł2.3b | zł472.3m | zł5.7m | 24.9x | 403.7x | 4.9x |
| Thu, 19 May 2022 | zł2.6b | zł424.4m | zł11.6m | 41.5x | 224.5x | 6.2x |
| Sat, 16 Apr 2022 | zł2.7b | zł366.7m | -zł37,207,677.00 | 33.2x | -73.6x | 7.5x |
| Mon, 14 Mar 2022 | zł2.7b | zł348.8m | -zł40,884,677.00 | 28.4x | -65.3x | 7.7x |
| Wed, 09 Feb 2022 | zł3.2b | zł369.9m | -zł24,922,742.00 | 51.2x | -128.2x | 8.6x |
| Fri, 07 Jan 2022 | zł3.7b | zł369.9m | -zł24,922,742.00 | 49.2x | -147.6x | 9.9x |
Price to Earnings Ratio
-147.6x
Current Industry PE
- Investors are pessimistic on the Polish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 4.5x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 3.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 0.085% | |
| Healthcare | 1.87% | |
| Biotech | 3.44% | |
| Biotech | 3.44% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SVE Synthaverse | zł4.52 | 9.2% +zł26.7m | 5.9% | PE71.4x | |
| BCX Bioceltix | zł87.60 | 2.1% +zł8.9m | -2.7% | PB10.4x | |
| MAB Mabion | zł8.90 | 5.2% +zł7.1m | -51.0% | PE14x | |
| BIO BIOTON | zł2.89 | 2.7% +zł6.4m | -19.2% | PS1.4x | |
| GMT Genomtec | zł7.86 | 4.7% +zł4.7m | -27.6% | PS104731.1x |
